EX-10.15 6 d208968dex1015.htm MASTER CONTRACT SERVICES AGREEMENT CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED...Master Contract Services Agreement • May 5th, 2020 • New York
THIS MASTER CONTRACT SERVICES AGREEMENT (the “Master Contract Services Agreement”) is made as of the Effective Date set forth above by and between Coronado Biosciences, Inc , a Delaware company with an office at 1700 Seventh Avenue, Seattle, WA 98101 (“CORONADO”) and Progenitor Cell Therapy, LLC, a Delaware limited liability company, with a principal office at 4 Pearl Court, Suite C, Allendale, NJ 07401 (the “Service Provider”) (the Master Contract Services Agreement, together with any Statement(s) of Work (as defined below), all Appendixes attached hereto, is collectively referred to as the “Agreement”). Terms not otherwise defined will have the meaning set forth for such term in Appendix B attached hereto, made a part hereof and incorporated herein by reference.
EX-10 9 filename9.htm [*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. SERVICE PROVIDER: • PPD...Master Contract Services Agreement • May 5th, 2020 • New York
THIS MASTER CONTRACT SERVICES AGREEMENT (together with any Work Orders, the “Agreement”) is made as of January 2, 2012 (the “Effective Date”) by and between Portola Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at 270 East Grand Avenue, Suite 22, South San Francisco, CA 94080 (Tel: 650-246-7300) (“Portola”) and PPD Development, LP, a Texas Limited Partnership, with a principal office at 929 North Front Street, Wilmington, NC 28401 (Tel: 949-293-1016) (“Service Provider”).
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • November 9th, 2021
This Master Contract Services Agreement (“Agreement”) shall enter into force on the day of its signing by the parties and shall take effect on the day following its publication in the Slovakian Central Register of Contracts (“Effective Date”), between Alnylam Switzerland GmbH, a company having its principal place of business at Grafenauweg 4, 6300 Zug, Switzerland (“ALNYLAM”) and Medical Faculty - Comenius University, Spitalska 24, Bratislava, 01 813 7, Slovakia (“Vendor”). ALNYLAM and Vendor may also be referred to herein individually as a “Party,” and collectively, as the “Parties”.
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • March 26th, 2024 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS MASTER CONTRACT SERVICES AGREEMENT (together with Appendix A and any Statement(s) of Work (as defined in Section 1), the “Agreement”) is made on October 17, 2023 (the “Effective Date”) by and between Tectonic Therapeutic, Inc., a Delaware corporation with an office at 490 Arsenal Way, Suite 210, Watertown, MA 02472 USA (“Tectonic”) and QPS Holdings, LLC, a Delaware limited liability company, with an office at 3 Innovation Way, Delaware Technology Park, Newark, DE 19711 USA (“Service Provider”).
HAS BEEN OMITTED BECAUSE TECTONIC THERAPEUTIC, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) IS THE TYPE THAT TECTONIC THERAPEUTIC, INC. TREATS AS PRIVATE OR CONFIDENTIAL.” MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • March 26th, 2024 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS MASTER CONTRACT SERVICES AGREEMENT (together with Appendix A and any Statement(s) of Work (as defined in Section I), the “Agreement”) is made on February 16,2022 (the “Effective Date”) by and between Tectonic Therapeutic, Inc., a Delaware corporation with an office at 490 Arsenal Way, Suite 210, Watertown, MA 02472 (“Tectonic”) ITR LABORATORIES CANADA INC., a Canadian established corporation with an office at 19601 Clark Graham Avenue, Baie D’Urfe, Quebec H9X 3T1 Canada (“Service Provider”).
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • August 24th, 2011 • Coronado Biosciences Inc • Pharmaceutical preparations • New York
THIS MASTER CONTRACT SERVICES AGREEMENT (together with any Statement(s) of Work, the “Agreement”) is made as of the date written above (the “Effective Date”) by and between Coronado Biosciences, Inc. , a Delaware company with an office at 4365 Executive Drive, Suite 1500, San Diego, California 92121 (“CORONADO”) and BioReliance Corporation, a Delaware corporation, with a principal office at 14920 Broschart Road, Rockville, MD 20850 (the “Service Provider”).
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • July 6th, 2021 • Biofrontera Inc. • Pharmaceutical preparations • Massachusetts
THIS MASTER CONTRACT SERVICES AGREEMENT (together with any Statement(s) of Work, the “Agreement”) is made as of July 2, 2021 (the “Effective Date”) by and between Biofrontera, Inc., a company with an office at 120 Presidential Way, Suite 330, Woburn, MA 01801 (“COMPANY”) and Biofrontera AG, a German corporation with a principal office at Hemmelrather Weg 201, 51377 Leverkusen, together with its wholly owned subsidiaries Biofrontera Pharma GmbH, a German company with a principal office at Hemmelrather Weg 201, 51377 Leverkusen, and Biofrontera Bioscience GmbH, a German company with a principal office at Hemmelrather Weg 201, 51377 Leverkusen (collectively, the “Service Provider”). Throughout this Agreement, COMPANY and Service Provider may be referred to as a “Party” or collectively as the “Parties.”
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • May 12th, 2014 • Civitas Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS MASTER CONTRACT SERVICES AGREEMENT (together with Appendix A and any Statement(s) of Work (as defined in Section 1), the “Agreement”) is made on September 26, 2013, (the “Effective Date”) by and between Civitas Therapeutics, Inc., a Delaware corporation with an office at 190 Everett Avenue, Chelsea, MA 02150 (“Civitas”) and Omega Plastics, Inc., a Michigan corporation with an office at 24401 Capital Blvd, Clinton Township, MI (“Service Provider”).
MASTER CONTRACT SERVICES AGREEMENT AMENDMENTMaster Contract Services Agreement • August 23rd, 2019 • Washington
New Leaf Services, LLC, (formerly 6858 Services, LLC), a Washington limited liability company and New Leaf Enterprises, Inc., a Washington corporation enter into this amendment
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • March 12th, 2019 • Synlogic, Inc. • Pharmaceutical preparations • Massachusetts
THIS MASTER CONTRACT SERVICES AGREEMENT (together with Appendix A and any Statement(s) of Work (as defined in Section 1), the “Agreement”) is made on 08 September, 2018 (the “Effective Date”) by and between Synlogic Operating Company, Inc., having offices at 301 Binney Street, Suite 402, Cambridge, MA 02142 (“Synlogic”) and Azzur Group (d/b/a Azzur of New England LLC), a Pennsylvania Limited Liability Company with an office at 411 Waverley Oaks Rd., #126, Waltham MA 02452 (“Service Provider”).
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • November 22nd, 2013 • Stratus Media Group, Inc • Services-amusement & recreation services • Massachusetts
THIS MASTER CONTRACT SERVICES AGREEMENT (together with any Statement(s) of Work, the “Agreement”) is made as of the date written above (the “Effective Date”) by and between Canterbury Laboratories, LLC, a Delaware limited liability company with a principal office at 8 Canterbury Lane, Holden, MA 01520 (“CANTERBURY’) and GLSynthesis Inc. (“Service Provider”), a Massachusetts corporation having a principal office at One Innovation Drive, Worcester, MA 01605.
